A Registration Study on Depression in Patients With Epilepsy

NCT03247764 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 320

Last updated 2022-01-11

No results posted yet for this study

Summary

The aim of this study is to register the drug treatment of depression in patients with epilepsy in East China.

Conditions

Interventions

OTHER

observational study

Sponsors & Collaborators

  • Shanghai Zhongshan Hospital

    lead OTHER

Principal Investigators

  • Xin Wang, PhD · Fudan University

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-02-01
Primary Completion
2021-12-31
Completion
2022-01-31

Countries

  • China

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03247764 on ClinicalTrials.gov